| 1. |
Papanicolaou, D. A., Wilder, R. L., Manolagas, S. C., and Chrousos, G. P. (1998) The pathophysiologic roles of interleukin-6
in human disease. Ann. Intern. Med.
128, 127–137.
|
| |
| 2. |
Baumann, H. and Gauldie, J. (1990) Regulation of hepatic acute phase plasma-protein genes by hepatocyte stimulating factors
and other mediators of inflammation. Mol. Biol. Med.
7, 147–159.
|
| |
| 3. |
Heinrich, P. C., Castell, J. V., and Andus, T. (1990) Interleukin-6 and the acute phase response. Biochem. J.
265, 621–636.
|
| |
| 4. |
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., and Hennekens, C. H. (1998) Prospective study of C-reactive protein and
the risk of future cardiovascular events among apparently healthy women. Circulation
98, 731–733.
|
| |
| 5. |
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., and Hennekens, C. H. (1997) Inflammation, aspirin, and the risk
of cardiovascular disease in apparently healthy men. N. Engl. J. Med.
336, 973–979.
|
| |
| 6. |
Ridker, P. M., Rifai, N., Stampfer, M. J., and Hennekens, C. H. (2000) Plasma concentration of interleukin-6 and the risk
of future myocardial infarction among apparently healthy men. Circulation
101, 1767–1772.
|
| |
| 7. |
Bauer, J., Ganter, U., Strauss, S., et al. (1992) The participation of interleukin-6 in the pathogenesis of Alzheimers disease.
Res. Immunol.
143, 650–656.
|
| |
| 8. |
Borg, S. A., Kerry, K. E., Royds, J. A., Battersby, R. D., and Jones, T. H. (2005) Correlation of VEGF production with IL1α
and IL6 secretion by human pituitary adenoma cells. Eur. J. Endocrinol.
152, 293–300.
|
| |
| 9. |
Filion, L. G., Graziani-Bowering, G., Matusevicius, D., and Freedman, M. S. (2003) Monocyte-derived cytokines in multiple
sclerosis. Clin. Exp. Immunol.
131, 324–334.
|
| |
| 10. |
Nagatsu, T. and Sawada, M. (2005) Inflammatory process in Parkinson. Curr. Pharm. Design
11, 999–1016.
|
| |
| 11. |
Waje-Andreassen, U., Krakenes, J., Ulvestad, E., et al. (2005) IL-6: an early marker for outcome in acute ischemic stroke.
Acta Neurol. Scand.
111, 360–365.
|
| |
| 12. |
Maier, B., Laurer, H. L., Rose, S., Buurman, W. A., and Marzi, I. (2005) Physiological levels of pro-and anti-inflammatory
mediators in cerebrospinal fluid and plasma: a normative study. J. Neurotrauma
22, 822–835.
|
| |
| 13. |
Penkowa, M., Giralt, M., Lago, N., et al. (2003) Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain
injury. Exp. Neurol.
181, 130–148.
|
| |
| 14. |
Goodey, A., Lavigne, J. J., Savoy, S. M., et al. (2001) Development of multianalyte sensor arrays composed of chemically derivatized
polymeric microspheres localized in micromachined cavities. J. Am. Chem. Soc.
123, 2559–2570.
|
| |
| 15. |
Lavigne, J. J., Savoy, S., Clevenger, M. B., et al. (1998) Solution-based analysis of multiple analytes by a sensor array:
Toward the development of an “electronic tongue.” J. Am. Chem. Soc.
120, 6429–6430.
|
| |
| 16. |
Gustavsson, P.-E., Axelsson, A., and Larsson, P.-O. (1999) Superporous agarose beads as a hydrophobic interaction chromatography
support. J. Chromatography A
830, 275–284.
|
| |
| 17. |
Gustavsson, P.-E. and Larsson, P.-O. (1996) Superporous agarose, a new material for chromatography. J. Chromatography A
734, 231–240.
|
| |
| 18. |
Gustavsson, P.-E., Mosbach, K., Nilsson, K., and Larsson, P.-O. (1997) Superporous agarose as an affinity chromatography support.
J. Chromatography A
776, 197–203.
|
| |